📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Aperio

1.1 - Company Overview

Aperio Logo

Aperio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of digital pathology solutions for hospitals, reference labs, and pharmaceutical and research institutions across the world, offering an affordable, complete portfolio that enhances quality assurance, delivers more efficient workflows, and improves patient care.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Aperio

Aparito Logo

Aparito

HQ: United Kingdom Website
  • Description: Provider of an eCOA platform (Atom5) that digitises clinical trials and captures real-world patient data via video assessments, ePROs, wearables, telemedicine, and eConsent, delivering real-time insights to clinical teams. Part 11, GDPR and HIPPA compliant, supporting patient-centric trials at scale in 193 countries and 125 languages.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aparito company profile →
ObvioHealth Logo

ObvioHealth

HQ: United States Website
  • Description: Provider of a no-code digital platform and app for study design and patient experience visualization; a virtual site team for scheduling, televisits, and personalized participant support; clinical science experts to identify digital endpoints and assist sponsors in achieving robust outcomes; a patient engagement suite combining a mobile app and easy data capture; remote patient monitoring with real-time adverse event detection; and ePRO/eCOA tools.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ObvioHealth company profile →
ePharma Solutions Logo

ePharma Solutions

HQ: United States Website
  • Description: Provider of e-clinical solutions that help sponsors, pharmaceutical companies, CROs, and investigator sites accelerate and improve clinical studies through better site selection, training, activation, and management. Offerings include Site Feasibility to find and activate qualified sites globally, and Rater and Patient Training to mitigate bias and variability, improving data quality and standardization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ePharma Solutions company profile →
Vyasa Logo

Vyasa

HQ: United States Website
  • Description: Provider of an AI-powered platform for life sciences and healthcare organizations, enabling businesses to integrate and analyze data across cloud and on-premise sources into a unified data platform. Offers Certara.AI, a secure platform for deploying life science-specific GPTs with real-time indexing of organizational data for drug development, clinical trials, and regulatory submission.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vyasa company profile →
ConcertAI Logo

ConcertAI

HQ: United States Website
  • Description: Provider of AI-powered SaaS medical research tools and integrated real-world data solutions for oncology. Offerings include AI-enriched datasets for clinical and outcomes research, regulatory-grade external control arms, pragmatic trials, post-approval studies, virtual EMR-claims registries, and regulatory research with custom real-world data abstraction and scientific consultation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ConcertAI company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Aperio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Aperio

2.2 - Growth funds investing in similar companies to Aperio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Aperio

4.2 - Public trading comparable groups for Aperio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Aperio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Aperio

What does Aperio do?

Aperio is a provider of digital pathology solutions for hospitals, reference labs, and pharmaceutical and research institutions across the world, offering an affordable, complete portfolio that enhances quality assurance, delivers more efficient workflows, and improves patient care.

Who are Aperio's competitors?

Aperio's competitors and similar companies include Aparito, ObvioHealth, ePharma Solutions, Vyasa, and ConcertAI.

Where is Aperio headquartered?

Aperio is headquartered in United States.

How many employees does Aperio have?

Aperio has 1,000 employees 🔒.

When was Aperio founded?

Aperio was founded in 2010 🔒.

What sector and industry vertical is Aperio in?

Aperio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Aperio

Who are the top strategic acquirers in Aperio's sector and industry

Top strategic M&A buyers and acquirers in Aperio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Aperio?

Top strategic M&A buyers groups and sectors for Aperio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Aperio's sector and industry vertical

Which are the top PE firms investing in Aperio's sector and industry vertical?

Top PE firms investing in Aperio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Aperio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Aperio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Aperio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Aperio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Aperio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Aperio?

The key public trading comparables and valuation benchmarks for Aperio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Aperio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Aperio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Aperio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Aperio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Aperio's' sector and industry vertical?

Access recent funding rounds and capital raises in Aperio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Aperio